Lifecore Historical Financial Ratios
| LFCR Stock | 7.28 0.11 1.53% |
Lifecore Biomedical is lately reporting on over 95 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 46.7 will help investors to properly organize and evaluate Lifecore Biomedical financial condition quickly.
Lifecore |
About Lifecore Financial Ratios Analysis
Lifecore BiomedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Lifecore Biomedical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Lifecore financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Lifecore Biomedical history.
Lifecore Biomedical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Lifecore Biomedical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Lifecore Biomedical sales, a figure that is much harder to manipulate than other Lifecore Biomedical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Payout Ratio
Payout Ratio is the proportion of Lifecore Biomedical earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of Lifecore Biomedical dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating Lifecore Biomedical is paying out more in dividends than it makes in net income.Most ratios from Lifecore Biomedical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Lifecore Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.As of 12/11/2024, Average Receivables is likely to drop to about 20.2 M
| 2010 | 2024 (projected) | null | 88.65 | 46.7 | null | 3.18 | 0.7 |
Lifecore Biomedical fundamentals Correlations
Click cells to compare fundamentals
Lifecore Biomedical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Lifecore Biomedical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifecore Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will appreciate offsetting losses from the drop in the long position's value.Moving together with Lifecore Stock
Moving against Lifecore Stock
| 0.92 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.86 | VALN | Valneva SE ADR | PairCorr |
| 0.86 | LLY | Eli Lilly | PairCorr |
| 0.84 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Lifecore Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifecore Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifecore Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifecore Biomedical to buy it.
The correlation of Lifecore Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifecore Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifecore Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifecore Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.